Cerebral microbleeds in patients with Parkinson’s disease

[1]  V. Mok,et al.  Race-Ethnicity and Cerebral Small Vessel Disease – Comparison between Chinese and White Populations , 2014, International journal of stroke : official journal of the International Stroke Society.

[2]  Maja A. A. Binnewijzend,et al.  Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease , 2013, Neurobiology of Aging.

[3]  Min Zhang,et al.  Relationship between cerebral microbleeds and cognitive function in lacunar infarct , 2013, The Journal of international medical research.

[4]  A. W. Chung,et al.  Cerebral Microbleeds and Cognition in Patients With Symptomatic Small Vessel Disease , 2013, Stroke.

[5]  D. Yang,et al.  Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease , 2012, Neurology.

[6]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[7]  Y. Sohn,et al.  Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  T. Satow,et al.  Periventricular and deep white matter leukoaraiosis have a closer association with cerebral microbleeds than age , 2012, European journal of neurology.

[9]  A. Blokland,et al.  Acetylcholine and attention , 2011, Behavioural Brain Research.

[10]  Y. Sohn,et al.  Comparison of Endothelial Progenitor Cells in Parkinson's Disease Patients Treated with Levodopa and Levodopa/COMT Inhibitor , 2011, PloS one.

[11]  Constantinos Kallis,et al.  Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? , 2011, Brain : a journal of neurology.

[12]  A. Hofman,et al.  Incidence of Cerebral Microbleeds in the General Population: The Rotterdam Scan Study , 2011, Stroke.

[13]  R. Kim,et al.  Cerebral Microbleeds in the Elderly: A Pathological Analysis , 2010, Stroke.

[14]  D. Yang,et al.  Influence of White Matter Hyperintensities on the Cognition of Patients With Parkinson Disease , 2010, Alzheimer disease and associated disorders.

[15]  Y. Shim,et al.  Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[16]  Rudie Kortekaas,et al.  Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration , 2009, Neurobiology of Aging.

[17]  R. Camicioli,et al.  Circulating Endothelial Progenitor Cells and Age-Related White Matter Changes , 2009, Stroke.

[18]  H. Vrooman,et al.  Lobar distribution of cerebral microbleeds: The Rotterdam scan study , 2009, Alzheimer's & Dementia.

[19]  D. Aarsland,et al.  Cognitive impairment in incident, untreated Parkinson disease , 2009, Neurology.

[20]  M. Ferrari,et al.  MRI correlates of cognitive decline in CADASIL , 2009, Neurology.

[21]  Y. Nanri,et al.  Brain Microbleeds and Global Cognitive Function in Adults Without Neurological Disorder , 2008, Stroke.

[22]  J. Kril,et al.  Neuropathologic correlates of white matter hyperintensities , 2008, Neurology.

[23]  M. Lubberink,et al.  Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease. , 2008, Parkinsonism & related disorders.

[24]  R. Rouhl,et al.  Endothelial Progenitor Cell Research in Stroke: A Potential Shift in Pathophysiological and Therapeutical Concepts , 2008, Stroke.

[25]  A. Hofman,et al.  Prevalence and risk factors of cerebral microbleeds , 2008, Neurology.

[26]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[27]  U. Yoon,et al.  Clinical Significance of Microbleeds in Subcortical Vascular Dementia , 2007, Stroke.

[28]  R. Truog,et al.  The controversy over artificial hydration and nutrition , 2006, Neurology.

[29]  H. Koennecke.  Cerebral microbleeds on MRI , 2006, Neurology.

[30]  Roger T Staff,et al.  Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. , 2005, Radiology.

[31]  P. Wolf,et al.  Cerebral Microbleeds: Prevalence and Associations With Cardiovascular Risk Factors in the Framingham Study , 2004, Stroke.

[32]  D. Werring,et al.  Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. , 2004, Brain : a journal of neurology.

[33]  J. Roh,et al.  Comparative analysis of the spatial distribution and severity of cerebral microbleeds and old lacunes , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[34]  V. Feigin,et al.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century , 2003, The Lancet Neurology.

[35]  Y. Itoyama,et al.  Silent Cerebral Microbleeds on T2*-Weighted MRI: Correlation with Stroke Subtype, Stroke Recurrence, and Leukoaraiosis , 2002, Stroke.

[36]  A Hofman,et al.  Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.

[37]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[38]  D. Aarsland,et al.  Risk of dementia in Parkinson’s disease , 2001, Neurology.

[39]  P Kapeller,et al.  Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. , 1999, AJNR. American journal of neuroradiology.

[40]  D. Na,et al.  Normative data on the Korean version of the Boston Naming Test. , 1999, Journal of clinical and experimental neuropsychology.

[41]  J. Stam,et al.  Silent intracerebral microhemorrhages in patients with ischemic stroke , 1998, Annals of neurology.

[42]  Yu-Min Kuo,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[43]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[44]  F. Telang,et al.  Risk factors for white matter changes detected by magnetic resonance imaging in the elderly. , 1990, Stroke.

[45]  J. Cummings,et al.  Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates , 1988, Journal of geriatric psychiatry and neurology.

[46]  H. Vinters.  Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.

[47]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[48]  W. Poewe.  Dysautonomia and cognitive dysfunction in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[49]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[50]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[51]  M. Emre.  Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.